Evidence map›Paper›PMID 36589679›Full record

ArticleOxidative medicine and cellular longevity2022

Inhibition of the TLR/NF-

Yan Su, Mao Li, Qi Wang, Xingfeng Xu, Peifang Qin, Haitao Huang, Yuting Zhang, Yali Zhou, Jianguo Yan

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oxidative medicine and cellular longevity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yan SuDepartment of Physiology, Guilin Medical University, Guilin, 541199 Guangxi, China.ORCID https://orcid.org/0000-0002-8292-3831
Mao LiDepartment of Physiology, Guilin Medical University, Guilin, 541199 Guangxi, China.
Qi WangDepartment of Physiology, Guilin Medical University, Guilin, 541199 Guangxi, China.
Xingfeng XuDepartment of Physiology, Guilin Medical University, Guilin, 541199 Guangxi, China.
Peifang QinDepartment of Microbiology, Guilin Medical University, Guilin, 541199 Guangxi, China.
Haitao HuangDepartment of Microbiology, Guilin Medical University, Guilin, 541199 Guangxi, China.
Yuting ZhangDepartment of Microbiology, Guilin Medical University, Guilin, 541199 Guangxi, China.
Yali ZhouDepartment of Microbiology, Guilin Medical University, Guilin, 541199 Guangxi, China.ORCID https://orcid.org/0000-0001-7571-5316
Jianguo YanDepartment of Physiology, Guilin Medical University, Guilin, 541199 Guangxi, China.ORCID https://orcid.org/0000-0003-4601-4830
Guilin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A naphthoquinone molecule known as plumbagin (PL), which has a wide range of pharmacological properties including antitumor, antioxidation, anti-inflammation, and neuroprotective effects, is extracted from the roots of the medicinal herb

Indexed as

NaphthoquinonesNeuroblastomaNeuroprotective AgentsParkinson Disease1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAnimalsAutophagyDisease Models, AnimalDopaminergic NeuronsHumansMiceMice, Inbred C57BLNF-kappa BProbenecidRatsSignal Transduction1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineNaphthoquinonesNeuroprotective AgentsNF-kappa BplumbaginProbenecid

Identifiers

PMID36589679
PMCPMC9800084
OpenAlexW4312190989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.